RxDoctor Payments Data

Hosep Deyrmenjian

Gastroenterology · Gurnee, ILNPI 1710979729

Payments from drug & device makers

What this record shows

This record is dominated by other: $16,849 of the $18,947 with a category attached, or 88.9%. Olympus America Inc. accounts for 88.9% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $16,849, more than ten times the $578 reported in 2019.

$18,947in general payments, 2019–2025

Across 111 payments — averaging $170.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus America Inc.$17K
  • Gilead$511
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$395
  • Intercept Pharmaceuticals, Inc.$264
  • Novo Nordisk$225
  • Romark Laboratories, LC$158
  • plus $544 from 11 others

What the payments were for

  • Consulting fees$510%
  • Food & beverage$2,04711%
  • Other$16,84989%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,947 in reported general payments places this provider in the 85th percentile of 787 gastroenterology providers in Illinois.

See all gastroenterology providers in Illinois →

Other gastroenterology in Gurnee

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →